Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

10 Jul 2013 09:03

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) was informed yesterday that Matthew Wineinger, a Person Discharging Managerial Responsibility, disposed of 131,933 ordinary shares of 25 pence each on 9 July 2013 on the London Stock Exchange at a price of 880.00 pence per share. Mr Wineinger has already met the requirements of the Company’s Executive Shareholding Policy.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

10 July 2013

Copyright Business Wire 2013

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.